Candida vulvovaginitis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
m Mehdi Pahlavani moved page Candidiasis cost-effectiveness of therapy to Candida vulvovaginitis cost-effectiveness of therapy without leaving a redirect |
No edit summary |
||
Line 18: | Line 18: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gynecology]] | |||
[[Category:Obstetrics]] |
Revision as of 21:27, 13 September 2017
Candida vulvovaginitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Candida vulvovaginitis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Candida vulvovaginitis cost-effectiveness of therapy |
Candida vulvovaginitis cost-effectiveness of therapy in the news |
Blogs on Candida vulvovaginitis cost-effectiveness of therapy |
Risk calculators and risk factors for Candida vulvovaginitis cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.